Prognostic value of stress echocardiography assessed by the ABCDE protocol.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
01 10 2021
Historique:
received: 16 03 2021
revised: 04 05 2021
accepted: 19 07 2021
pubmed: 28 8 2021
medline: 1 6 2022
entrez: 27 8 2021
Statut: ppublish

Résumé

The aim of this study was to assess the prognostic value of ABCDE-SE in a prospective, large scale, multicentre, international, effectiveness study. Stress echocardiography (SE) was recently upgraded to the ABCDE protocol: step A, regional wall motion abnormalities; step B, B lines; step C, left ventricular contractile reserve; step D, Doppler-based coronary flow velocity reserve in left anterior descending coronary artery; and step E, electrocardiogram-based heart rate reserve. From July 2016 to November 2020, we enrolled 3574 all-comers (age 65 ± 11 years, 2070 males, 58%; ejection fraction 60 ± 10%) with known or suspected chronic coronary syndromes referred from 13 certified laboratories. All patients underwent clinically indicated ABCDE-SE. The employed stress modality was exercise (n = 952, with semi-supine bike, n = 887, or treadmill, n = 65 with adenosine for step D) or pharmacological stress (n = 2622, with vasodilator, n = 2151; or dobutamine, n = 471). SE response ranged from score 0 (all steps normal) to score 5 (all steps abnormal). All-cause death was the only endpoint. Rate of abnormal results was 16% for A, 30% for B, 36% for C, 28% for D, and 37% for E steps. During a median follow-up of 21 months (interquartile range: 13-36), 73 deaths occurred. Global X2 was 49.5 considering clinical variables, 50.7 after step A only (P = NS (not significant)) and 80.6 after B-E steps (P < 0.001 vs. step A). Annual mortality rate ranged from 0.4% person-year for score 0 up to 2.7% person-year for score 5. ABCDE-SE allows an effective prediction of survival in patients with chronic coronary syndromes.

Identifiants

pubmed: 34449837
pii: 6358074
doi: 10.1093/eurheartj/ehab493
pmc: PMC8486488
doi:

Substances chimiques

Dobutamine 3S12J47372

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3869-3878

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Am J Cardiol. 2019 Sep 15;124(6):972-977
pubmed: 31324358
J Clin Med. 2020 Sep 30;9(10):
pubmed: 33008112
J Am Coll Cardiol. 2019 Sep 24;74(12):1582-1593
pubmed: 31537269
J Am Coll Cardiol. 1999 Sep;34(3):618-20
pubmed: 10483939
Circulation. 2011 Mar 8;123(9):1010-20
pubmed: 21382903
J Am Soc Echocardiogr. 2020 Jan;33(1):1-41.e8
pubmed: 31740370
JACC Cardiovasc Imaging. 2020 Oct;13(10):2085-2095
pubmed: 32682714
J Am Soc Echocardiogr. 2017 Feb;30(2):101-138
pubmed: 28164802
J Am Coll Cardiol. 2003 Sep 3;42(5):823-30
pubmed: 12957427
Eur J Heart Fail. 2017 Nov;19(11):1468-1478
pubmed: 28198075
J Am Coll Cardiol. 2020 Sep 29;76(13):1605-1606
pubmed: 32745501
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Eur Heart J. 2006 Dec;27(24):3039-44
pubmed: 17132654
Card Fail Rev. 2018 Aug;4(2):92-98
pubmed: 30206483
Echocardiography. 2005 Mar;22(3):225-32
pubmed: 15725157
J Am Coll Cardiol. 2019 Nov 5;74(18):2278-2291
pubmed: 31672185
Arch Cardiovasc Dis. 2020 Apr;113(4):244-251
pubmed: 32241716
Eur Heart J. 2014 May;35(17):1101-11
pubmed: 24366916
JACC Cardiovasc Imaging. 2020 Jul;13(7):1615-1626
pubmed: 32646721
J Am Coll Cardiol. 2012 Sep 11;60(11):951-6
pubmed: 22954239
JACC Cardiovasc Imaging. 2020 Mar;13(3):866-872
pubmed: 31422148
J Am Soc Echocardiogr. 2016 Aug;29(8):736-744
pubmed: 27112362
Prog Cardiovasc Dis. 2006 Mar-Apr;48(5):342-62
pubmed: 16627049
Cardiovasc Ultrasound. 2017 Jan 18;15(1):3
pubmed: 28100277
J Am Coll Cardiol. 2019 Mar 26;73(11):1317-1335
pubmed: 30898208
Eur Heart J. 2009 Feb;30(3):278-89
pubmed: 19001473
Int J Cardiol. 2017 Dec 15;249:479-485
pubmed: 28986062
J Am Soc Echocardiogr. 2018 Jun;31(6):692-701
pubmed: 29625884

Auteurs

Quirino Ciampi (Q)

Cardiology Division, Fatebenefratelli Hospital, Benevento, Italy.

Angela Zagatina (A)

Cardiology Department, Saint Petersburg State University Hospital, Russian Federation.

Lauro Cortigiani (L)

Cardiology Department, San Luca Hospital, Lucca, Italy.

Karina Wierzbowska-Drabik (K)

Chair of Cardiology, Bieganski Hospital, Medical University, Lodz, Poland.

Jaroslaw D Kasprzak (JD)

Chair of Cardiology, Bieganski Hospital, Medical University, Lodz, Poland.

Maciej Haberka (M)

Department of Cardiology, SHS, Medical University of Silesia, Katowice, Poland.

Ana Djordjevic-Dikic (A)

Cardiology Clinic, Clinical Center of Serbia, Medical School, University of Belgrade, Belgrade, Serbia.

Branko Beleslin (B)

Cardiology Clinic, Clinical Center of Serbia, Medical School, University of Belgrade, Belgrade, Serbia.

Alla Boshchenko (A)

Cardiology Research Institute, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russian Federation.

Tamara Ryabova (T)

Cardiology Research Institute, Tomsk National Research Medical Centre of the Russian Academy of Sciences, Tomsk, Russian Federation.

Nicola Gaibazzi (N)

Cardiology Department, Parma University Hospital, Parma, Italy.

Fausto Rigo (F)

Cardiology Department, Ospedale di Dolo-Venice, Venice, Italy.

Claudio Dodi (C)

Cardiology Department, Ospedale di Cremona, Cremona, Italy.

Iana Simova (I)

Cardiology Department, Heart and Brain Center of Excellence, University Hospital, Pleven, Sofia, Bulgaria.

Martina Samardjieva (M)

Cardiology Department, Heart and Brain Center of Excellence, University Hospital, Pleven, Sofia, Bulgaria.

Andrea Barbieri (A)

Noninvasive Cardiology, University Hospital, Parma, Italy.

Doralisa Morrone (D)

Cardiothoracic Department, University of Pisa, Italy.

Valentina Lorenzoni (V)

Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.

Costantina Prota (C)

San Luca Hospital, Vallo della Lucania, Italy.

Bruno Villari (B)

Cardiology Division, Fatebenefratelli Hospital, Benevento, Italy.

Francesco Antonini-Canterin (F)

Highly Specialized Rehabilitation Hospital Motta di Livenza, Cardiac Prevention and Rehabilitation Unit, Treviso, Italy.
Italian Society of Echocardiography and Cardiovascular Imaging, Milano, Italy.

Mauro Pepi (M)

Italian Society of Echocardiography and Cardiovascular Imaging, Milano, Italy.
Cardiology Division, Fondazione Cardiologica Monzino, Milano, Italy.

Clara Carpeggiani (C)

Biomedicine Department, CNR, Institute of Clinical Physiology, Via Moruzzi 1, Building C- Room 130, 56124 Pisa, Italy.

Patricia A Pellikka (PA)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Eugenio Picano (E)

Biomedicine Department, CNR, Institute of Clinical Physiology, Via Moruzzi 1, Building C- Room 130, 56124 Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH